暂无推荐供应商。我要出现这里
化源商城直购
[1]. Daley W, et, al. Evive successfully concludes first phase III clinical trial of F-627 for chemotherapy-induced neutropenia and met primary endpoints. Shanghai, China: Evive Biotech; January 25, 2018.